$1.40
-0.04 (-2.78%)
Open$1.40
Previous Close$1.44
Day High$1.43
Day Low$1.39
52W High$5.50
52W Low$1.16
Volume—
Avg Volume45.1K
Market Cap5.23M
P/E Ratio—
EPS$-1.41
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+224.3% upside
Current
$1.40
$1.40
Target
$4.54
$4.54
$3.16
$4.54 avg
$6.69
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 8.11M | 7.07M | 1.27M |
| Net Income | -9,930,353 | -7,790,548 | 357.5K |
| Profit Margin | -122.5% | -116.3% | 28.2% |
| EBITDA | -10,235,780 | -8,476,282 | 531.9K |
| Free Cash Flow | — | — | 275.9K |
| Rev Growth | +14.7% | +14.7% | -7.0% |
| Debt/Equity | — | — | 0.71 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |